Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
- 1 August 2020
- journal article
- review article
- Published by Elsevier BV in Transfusion and Apheresis Science
- Vol. 59 (4), 102817
- https://doi.org/10.1016/j.transci.2020.102817
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaJAMA, 2020
- Convalescent Plasma to Treat COVID-19JAMA, 2020
- The convalescent sera option for containing COVID-19JCI Insight, 2020
- Convalescent plasma as a potential therapy for COVID-19The Lancet Infectious Diseases, 2020
- Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patientsIntensive Care Medicine, 2016
- Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolSpringerPlus, 2015
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysisThe Journal of Infectious Diseases, 2014
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patientsClinical Microbiology & Infection, 2004
- Passively Acquired Antibodies Suppress Humoral But Not Cell-Mediated Immunity in Mice Immunized with Live Attenuated Respiratory Syncytial Virus VaccinesThe Journal of Immunology, 2001